Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Journal of Infection and Public Health. 2013; 6 (2): 69-79
in English | IMEMR | ID: emr-142703

ABSTRACT

Southeast Asia remains a critical region for the emergence of novel and/or zoonotic influenza, underscoring the importance of extensive sampling in rural areas where early transmission is most likely to occur. In 2008, 800 adult participants from eight sites were enrolled in a prospective population-based study of avian influenza [AI] virus transmission where highly pathogenic avian influenza [HPAI] H5N1 virus had been reported in humans and poultry from 2006 to 2008. From their enrollment sera and questionnaires, we report risk factor findings for serologic evidence of previous infection with 18 AI virus strains. Serologic assays revealed no evidence of previous infection with 13 different low-pathogenic AI viruses or with HPAI avian-like A/Cambodia/R0404050/2007[H5N1]. However, 21 participants had elevated antibodies against avian-like A/Hong Kong/1073/1999[H9N2], validated with a monoclonal antibody blocking ELISA assay specific for avian H9. Although cross-reaction from antibodies against human influenza viruses cannot be completely excluded, the study data suggest that a number of participants were previously infected with the avian-like A/Hong Kong/1073/1999[H9N2] virus, likely due to as yet unidentified environmental exposures. Prospective data from this cohort will help us better understand the serology of zoonotic influenza infection in a rural cohort in SE Asia


Subject(s)
Humans , Male , Female , Influenza, Human/epidemiology , Disease Outbreaks , Influenza, Human/transmission , Influenza, Human/virology , Enzyme-Linked Immunosorbent Assay , Antibodies, Viral/blood , Occupational Exposure , Prospective Studies , Surveys and Questionnaires , Rural Population/statistics & numerical data , Animals , Cohort Studies
2.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 210-219, 2012.
Article in English | WPRIM | ID: wpr-85812

ABSTRACT

Globally, acute malnutrition triggers more than 50% of childhood mortality in children under 5 years old, which implies that about 3.5 million children die of malnutrition each year. Prior to the advent of ready-to-use therapeutic food (RUTF), the management of acute malnutrition was limited to hospitals, resulting in low coverage rates with high mortality, as malnourished cases were indentified at later stages often plagued with complications. However, current availability of RUTF has enabled malnourished children to be treated at communities. Further, because RUTF is dehydrated and sealed, it has the added advantage of a lower risk of bacterial contamination, thereby prolonging its storage life at room temperature. Recent data indicate that Community Management of Acute Malnutrition (CMAM) is as cost effective as other high-impact public health measures such as oral rehydration therapy for acute diarrheal diseases, vitamin A supplementation, and antibiotic treatment for acute respiratory infections. Despite the high efficacy of CMAM programs, CMAM still draws insufficient attention for global implementation, suggesting that CMAM programs should be integrated into local or regional routine health systems. Knowledge gaps requiring further research include: the definition of practical screening criteria for malnourished children at communities, the need for systematic antibiotic therapy during malnutrition treatment, and the dietary management of severe malnutrition in children below 6 months of age.


Subject(s)
Child , Humans , Child Nutrition Disorders , Developing Countries , Fluid Therapy , Imidazoles , Malnutrition , Mass Screening , Nitro Compounds , Public Health , Respiratory Tract Infections , Vitamin A
SELECTION OF CITATIONS
SEARCH DETAIL